The role of 5-HTR2C in POMC neurons and the new role in neural circuits suggest that the new anti-obesity drugs act directly on the CNS, thereby reducing the negative effects caused by acting on the periphery, which will be discussed in the future. Here, POMC is linked to obesity due to melanocortin 4 receptor deficiency.